HLA-A24.2/B2M(2)
Nomenclature
C57BL/6JSmo-B2mtm1(hB2M-linker-HLA-A*2402/H2-D1)Smoc
Cat. NO.
NM-HU-241352
Strain State
Repository Live
Gene Summary
Gene Symbol
B2M
Model Description
Validation Data

Fig.1 Detection of HLA-A24.2/B2M expression in spleen and liver by RT-PCR.
Spleen and liver RNA were extracted from wild-type C57BL/6 mice (WT) and homozygous hHLA-A24.2/hB2M(2) knockin mice (HO) (n=2, male, 9 weeks old), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. Mouse B2m mRNA (297 bp) was detectable only in wild-type C57BL/6 mice. Human HLA-A24.2 (624bp) and human B2M mRNA (158 bp) was detectable only in homozygous hHLA-A24.2/hB2M(2) knockin mice but not in wild-type mice.

Fig.2 Expression analysis of hB2M(A) and HLA-ABC(B) on CD45+ cells in blood of HLA-A24.2/B2M humanized mice.
Leukocytes were collected from wild-type C57BL/6 mice(11 weeks old) and homozygous HLA-A11.1/B2M humanized mice(13.4 weeks old) , and analyzed by flow cytometry with anti-mB2M, anti-hB2M, anti-mH2D and anti-HLA-ABC. hB2M and HLA-ABC were exclusively detectable in HLA-A24.2/B2M humanized mice, whereas mB2M and mH2D were exclusively detectable in wild-type C57BL/6 mice.

Fig.3 Detection of immune cell subpopulations in the blood of male mice by FACS (n=3 in all groups, 13 weeks).
Abbr. WT, wild type; HO, homozygous.

Fig.4 Detection of immune cell subpopulations in the blood of female mice by FACS (n=3 in all groups, 13 weeks).
Abbr. WT, wild type; HO, homozygous.

Fig.5 Detection of immune cell subpopulations in the spleen of male mice by FACS (n=3 in all groups, 13 weeks).
Abbr. WT, wild type; HO, homozygous.

Fig.6 Detection of immune cell subpopulations in the spleen of female mice by FACS (n=3 in all groups, 13 weeks).
Abbr. WT, wild type; HO, homozygous.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more